MYOFASCIAL PAIN
- Authors: Vorobyova OV1, Vorob'eva O.V.1
-
Affiliations:
- Issue: No 13 (2010)
- Pages: 20-25
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278531
- ID: 278531
Cite item
Full Text
Abstract
The article is dedicated to the clinical aspects of myofascial pain syndrome (MFS); the prevalence of this syndrome may amount 54% in women and 45% in men. According to the traditional definition of MFS, muscle pain develops from the limited areas of muscles called as trigger points (TP). The causes and mechanisms of development of MFS are discussed. Modern approaches to treatment of MFS are presented. It is emphasized that the main short-term goal is the destruction of TP that leads to the pain reduction. Nonsteroidal anti-inflammatory drugs, especially Ketorolac (Ketorol), play important role in the treatment of MFS. The positive effects of Ketorol (Ketorolac) are significant analgesia comparable to narcotic analgesics, prolonged anesthesia - more than 6 hours, the rapid development of analgesia in oral administration - in 15-20 minutes, and favorable efficacy/safety ratio.
References
- Тревелл Дж.Г., Симонс Д.Г. Миофасциальные боли. М., 1989. Т. 1-2.
- Bezerra Rocha CA, Sanchez TG, Tesseroli de Siqueira JT. Myofascial trigger point: a possible way of modulating tinnitus. Audiol Neurootol 2008;13:153-60.
- Fernandez-de-Las-Penas C, Ge HY, Arendt-Nielsen L, et al. The local and referred pain from myofascial trigger points in the temporalis muscle contributes to pain profile in chronic tension-type headache. Clin J Pain. 2007;23:786-92.
- Gerwin R, Shannon S. Interexaminer reliability and myofascial trigger points. Arch Phys Med Rehabil 2000;81:1257-8.
- Ge HY, Fernández-de-Las-Peñas C, Madeleine P, et al. Topographical mapping and mechanical pain sensitivity of myofascial trigger points in the infraspinatus muscle. Eur J Pain. 2008;12:859-65.
- Hsieh CY, Hong CZ, Adams AH, et al. Interexaminer reliability of the palpation of trigger points in the trunk and lower limb muscles. Arch Phys Med Rehabil 2000;81:258-64.
- Pongratz DE, Sievers M. Fibromyalgia-symptom or diagnosis: adefinition of the position. Scand J Rheumatol Suppl 2000;113:3-7.
- Simons DG, Travell JG, Simons LS, et al. Travell and Simons' myofascial pain and dysfunction the trigger point manual. 2th ed.Baltimore: Williams and Wilkins 1999.
- Janda V. Muscle Function Testing. London: Butterworths, 1983.
- Borg-Stein J, Simons DG. Focused review: myofascial pain. Arch Phys Med Rehabil 2002;83(3):40-47.
- Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil 1998;79:863-72.
- Fischer AA. Myofascial Pain Update in Diagnosis and Treatment.Pennsylvania: Saunders, 1997.
- Simons DG. New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil 2008;89:157-9.
- Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 2008;89:16-23.
- Chang CW, Chen YR, Chang KF. Evidence of neuroaxonal degeneration in myofascial pain syndrome: a study of neuromuscular jitter by axonal microstimulation. Eur J Pain 2008;12:1026-30.
- Pongratz DE, Spath M. Morphologic aspects of muscle pain syndromes - A critical review. Pennsylvania: Saunders, 1997.
Supplementary files
